- Home
- CGEM vs IMOS Comparison
CGEM vs IMOS Comparison
Compare CGEM & IMOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEM
- IMOS
- Stock Information
- Founded
- CGEM 2016
- IMOS 1997
- Country
- CGEM United States
- IMOS Taiwan
- Employees
- CGEM N/A
- IMOS N/A
- Industry
- CGEM Biotechnology: Pharmaceutical Preparations
- IMOS Semiconductors
- Sector
- CGEM Health Care
- IMOS Technology
- Exchange
- CGEM Nasdaq
- IMOS Nasdaq
- Market Cap
- CGEM 730.2M
- IMOS 705.1M
- IPO Year
- CGEM 2021
- IMOS N/A
- Fundamental
- Price
- CGEM $12.39
- IMOS $18.82
- Analyst Decision
- CGEM Strong Buy
- IMOS
- Analyst Count
- CGEM 7
- IMOS 0
- Target Price
- CGEM $31.67
- IMOS N/A
- AVG Volume (30 Days)
- CGEM 546.1K
- IMOS 28.6K
- Earning Date
- CGEM 11-07-2024
- IMOS 02-20-2025
- Dividend Yield
- CGEM N/A
- IMOS 5.90%
- EPS Growth
- CGEM N/A
- IMOS 7.03
- EPS
- CGEM N/A
- IMOS 0.07
- Revenue
- CGEM N/A
- IMOS $724,842,895.00
- Revenue This Year
- CGEM N/A
- IMOS $15.65
- Revenue Next Year
- CGEM N/A
- IMOS $13.49
- P/E Ratio
- CGEM N/A
- IMOS $13.10
- Revenue Growth
- CGEM N/A
- IMOS 13.31
- 52 Week Low
- CGEM $10.00
- IMOS $18.20
- 52 Week High
- CGEM $30.19
- IMOS $32.19
- Technical
- Relative Strength Index (RSI)
- CGEM 47.96
- IMOS 40.10
- Support Level
- CGEM $11.75
- IMOS $18.65
- Resistance Level
- CGEM $12.95
- IMOS $18.95
- Average True Range (ATR)
- CGEM 0.76
- IMOS 0.34
- MACD
- CGEM 0.19
- IMOS 0.07
- Stochastic Oscillator
- CGEM 77.69
- IMOS 48.06
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, create differentiated ideas, identify the appropriate targets, and select the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications.
About IMOS ChipMOS TECHNOLOGIES INC.
ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. The Company derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.